Skip to content
Screener

Globus Medical GMED Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$759.9MBeat by $19.5M
EPS$1.12Beat by $0.20
Revenue estimate$740.3M
EPS estimate$0.92

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$792.2M
EPS estimate$1.20

Financials

Q1 2026

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$11.65B+15.7%
Enterprise value$11.21B+15.6%
P/E19.9×-34.4×
P/S3.8×-0.3×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Segments

By product

See full
Musculoskeletal Solutions$733.0M—
Enabling Technologies$26.9M—

By segment

See full
Reportable Segment$759.9M+27.0%

FAQ

When did Globus Medical report Q1 2026 earnings?
Globus Medical (GMED) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Globus Medical's Q1 2026 revenue and EPS?
Globus Medical reported revenue of $759.9M and eps of $1.12 for Q1 2026.
Did Globus Medical beat estimates in Q1 2026?
Revenue beat the consensus estimate of $740.3M by $19.5M. EPS beat the consensus estimate of $0.92 by $0.20.
How did Globus Medical's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 27.0% from $598.1M a year earlier and eps grew 64.7% from $0.68.
Where can I find Globus Medical's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-032164) and the 10-Q periodic report (0001628280-26-032290) directly on SEC EDGAR. The filing index links above go to sec.gov.